AbbVie Inc.
ABBVNew York Stock ExchangeFull coverage
Price
Loading your watchlists
Income statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions · shares in millions · per-share in USD · per-share values and share counts not split-adjusted
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, | FY 2018Ended Dec 31, | FY 2017Ended Dec 31, | FY 2016Ended Dec 31, | FY 2015Ended Dec 31, | FY 2014Ended Dec 31, | FY 2013Ended Dec 31, | FY 2012Ended Dec 31, | FY 2011Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Cost of revenue | ||||||||||||||||
| Cost of goods sold | ||||||||||||||||
| Gross profit | ||||||||||||||||
| Research and development | ||||||||||||||||
| Selling, general and administrative | ||||||||||||||||
| Restructuring charges | ||||||||||||||||
| Operating expenses | ||||||||||||||||
| Total costs and expenses | ||||||||||||||||
| Operating income | ||||||||||||||||
| Interest expense | ||||||||||||||||
| Interest and dividend income on investments | ||||||||||||||||
| Non-operating income (expense), net | ||||||||||||||||
| Other non-operating income (expense) | ||||||||||||||||
| Income before taxes | ||||||||||||||||
| Income tax | ||||||||||||||||
| Net income including non-controlling interests | ||||||||||||||||
| Net income attributable to non-controlling interests | ||||||||||||||||
| Net income | ||||||||||||||||
| Net income available to common shareholders | ||||||||||||||||
| Basic EPS | ||||||||||||||||
| Diluted EPS | ||||||||||||||||
| Weighted average shares (basic) | ||||||||||||||||
| Weighted average shares (diluted) | ||||||||||||||||
| Dividends per share | ||||||||||||||||
| Other comprehensive income, including non-controlling interests | ||||||||||||||||
| Unrealized gains (losses) on available-for-sale securities | ||||||||||||||||
| Cash flow hedges | ||||||||||||||||
| Pension and other postretirement benefit plans | ||||||||||||||||
| Other comprehensive income | ||||||||||||||||
| Comprehensive income, including non-controlling interests | ||||||||||||||||
| Comprehensive income attributable to non-controlling interests | ||||||||||||||||
| Comprehensive income | ||||||||||||||||
| Lease cost | ||||||||||||||||
| Operating lease cost | ||||||||||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years | 10 years |
|---|---|---|---|---|---|
| Revenue | |||||
| Gross profit | |||||
| Diluted EPS | |||||
| Free cash flow | |||||
| Dividends per share | |||||
| Diluted share count |
Margins
An item moved a margin in this period
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| FCF margin |